FDA.reportPublic FDA data

MONOSODIUM CITRATE

Substance profile for UNII 68538UP9SE, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for MONOSODIUM CITRATE
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
68538UP9SE
Preferred term
MONOSODIUM CITRATE
Registry number
18996-35-5
EC number
242-734-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H5O7.Na.2H
Chemical structure for MONOSODIUM CITRATE
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
HWPKGOGLCKPRLZ-UHFFFAOYSA-M
SMILES
[H+].[H+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
RxCUI
0
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchHWPKGOGLCKPRLZ-UHFFFAOYSA-Mpubchem.ncbi.nlm.nih.gov/#query=HWPKGOGLCKPRLZ-UHFFFAOYSA-M
FDA Substance Registration System68538UP9SEprecision.fda.gov/uniisearch/srs/unii/68538UP9SE
European Community number242-734-6commonchemistry.cas.org/results?q=242-734-6

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP, 600 mg/42.9 mg per 5 mL Rx only2
CEFUROXIME AXETIL FOR ORAL SUSPENSION,USP Rx Only1
These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for TAMIFLU. TAMIFLU ® (oseltamivir phosphate) capsules TAMIFLU ® (oseltamivir phosphate) for oral suspension Initial U.S. Approval: 19991
TAMIFLU (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION TAMIFLU (OSELTAMIVIR PHOSPHATE) CAPSULE [GENENTECH, INC.]30
BINOSTO (ALENDRONATE SODIUM) TABLET, EFFERVESCENT [MISSION PHARMACAL COMPANY]7
RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE ) TABLET, ORALLY DISINTEGRATING [BRECKENRIDGE PHARMACEUTICAL, INC.]4
TODAY VAGINAL CONTRACEPTIVE (NONOXYNOL-9) SPONGE [MAYER LABORATORIES, INC.]2
RIZATRIPTAN BENZOATE TABLET, ORALLY DISINTEGRATING [PROFICIENT RX LP]1
TAMIFLU (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION TAMIFLU (OSELTAMIVIR PHOSPHATE) CAPSULE [DISPENSING SOLUTIONS, INC.]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 68538UP9SE page 1 of 1 · 6 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
MONOSODIUM CITRATE68538UP9SE18996355GRANULE, EFFERVESCENTORALNA
MONOSODIUM CITRATE68538UP9SE18996355POWDER, FOR SUSPENSIONORAL550 mg
MONOSODIUM CITRATE68538UP9SE18996355SUSPENSIONORAL275 mg
MONOSODIUM CITRATE68538UP9SE18996355TABLETORAL50 mg
MONOSODIUM CITRATE68538UP9SE18996355TABLET, EFFERVESCENTORAL1900 mg
MONOSODIUM CITRATE68538UP9SE18996355TABLET, ORALLY DISINTEGRATINGORAL23 mg